-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H3vRzD1k42W4b4Lg8FwKDwAgcNDX9Lbc1eek0VZfTQrBY9d9RjdqgGqjQHdbu5gc x7+FLRXF6t5dosdg53qTgg== 0000899140-06-000127.txt : 20060127 0000899140-06-000127.hdr.sgml : 20060127 20060127172448 ACCESSION NUMBER: 0000899140-06-000127 CONFORMED SUBMISSION TYPE: S-8 POS PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060127 DATE AS OF CHANGE: 20060127 EFFECTIVENESS DATE: 20060127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IVAX CORP CENTRAL INDEX KEY: 0000772197 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 161003559 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 POS SEC ACT: 1933 Act SEC FILE NUMBER: 333-30692 FILM NUMBER: 06559159 BUSINESS ADDRESS: STREET 1: 4400 BISCAYNE BLVD CITY: MIAMI STATE: FL ZIP: 33137 BUSINESS PHONE: 3055756000 MAIL ADDRESS: STREET 1: 4400 BISCAYNE BOULEVARD CITY: MIAMI STATE: FL ZIP: 33137 FORMER COMPANY: FORMER CONFORMED NAME: IVAX CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: IVACO INDUSTRIES INC DATE OF NAME CHANGE: 19871213 FORMER COMPANY: FORMER CONFORMED NAME: INLAND VACUUM INDUSTRIES INC DATE OF NAME CHANGE: 19870611 S-8 POS 1 posam16.txt POST-EFFECTIVE AMENDMENT NO. 1 TO S-8 As filed with the Securities and Exchange Commission on January 27, 2006 Registration No. 333-30692 ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 IVAX CORPORATION (Exact name of registrant as specified in its charter) Florida 65-0507804 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) 4400 Biscayne Boulevard Miami, Florida 33137 (Address of Principal Executive Offices) ---------------------------------------------------------- IVAX Corporation 1999 Employee Stock Purchase Plan (Full title of the plans) ---------------------------------------------------------- Richard S. Egosi c/o Teva Pharmaceuticals USA, Inc. 425 Privet Road Horsham, Pennsylvania 19044 (215) 293-6400 (Name, address and telephone number, including area code, of agent for service) ---------------------------------------------------------- Copies to PETER H. JAKES, Esq. JEFFREY S. HOCHMAN, Esq. Willkie Farr & Gallagher LLP 787 Seventh Avenue New York, NY 10019 (212) 728-8000 ---------------------------------------------------------- ----------------------------------- DEREGISTRATION OF UNSOLD SECURITIES ----------------------------------- 6,020,902 shares of common stock of IVAX Corporation, par value $0.10 per share (the "Common Stock"), giving effect to the 3-for-2 stock split of the Common Stock in February 2000, the 5-for-4 stock split of the Common Stock in May 2001 and the 5-for-4 stock split of the Common Stock in August 2004, previously registered for sale to the public under this Registration Statement are hereby withdrawn from registration. Such Common Stock represents all the securities remaining unsold under this Registration Statement. SIGNATURES Pursuant to the requirements of the Securities Act, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Miami, State of Florida, January 27, 2006. IVAX CORPORATION By: /s/ George S. Barrett ------------------------------ George S. Barrett President (Chief Executive Officer) Pursuant to the requirements of the Securities Act of 1933, as amended, this Post-Effective Amendment No. 1 to the Registration Statement has been signed by the following persons in the capacities and on the dates indicated. Name Title(s) Date ---- -------- ---- /s/ George S. Barrett President (Chief Executive Officer) and Director January 27, 2006 - --------------------------- George S. Barrett /s/ Mark W. Durand Chief Financial Officer (Principal Financial January 27, 2006 - --------------------------- Officer and Principal Accounting Officer) Mark W. Durand /s/ William S. Marth Director January 27, 2006 - --------------------------- William S. Marth /s/ Richard S. Egosi Director January 27, 2006 - --------------------------- Richard S. Egosi
-----END PRIVACY-ENHANCED MESSAGE-----